Resveratrol: An Antiaging Drug with Potential Therapeutic Applications in Treating Diseases

Antoni Camins1, Felix Junyent2, Ester Verdaguer2

  • 1Unitat de Farmacologia i Farmacognòsia i Institut de Biomedicina (IBUB), Centro de Investigación de Biomedicina en Red de Enfermedades Neurodegenerativas (CIBERNED), Facultat de Farmàcia, Universitat de Barcelona, 08028 Barcelona, Spain. camins@ub.edu.

Insights

Resveratrol, a natural compound, activates sirtuin 1 (SIRT1) and exhibits antioxidant effects, suggesting its potential as an anti-aging drug. This activation influences key proteins involved in cellular aging and disease treatment.

Area of Science:

  • Biomedicine
  • Gerontology
  • Molecular Biology

Background:

  • Cellular aging is influenced by biochemical pathways, with free radicals playing a significant role.
  • Sirtuins, particularly sirtuin 1 (SIRT1), have emerged as key regulators with anti-aging properties.
  • Understanding these pathways is crucial for developing effective aging prevention strategies.

Approach:

  • This review focuses on the natural compound resveratrol and its dual action: antioxidant effects and sirtuin activation.
  • Investigates resveratrol's modulation of critical proteins like peroxisome proliferator-activated receptor coactivator-1α (PGC-1 alpha), FOXO family, Akt, and NFκβ.
  • Synthesizes current knowledge on resveratrol's impact on cellular aging mechanisms.

Key Points:

  • Resveratrol demonstrates potent activation of sirtuin 1 (SIRT1).
  • Resveratrol possesses significant antioxidant properties, counteracting cellular damage.
  • Activation of SIRT1 by resveratrol influences multiple protein pathways (PGC-1 alpha, FOXO, Akt, NFκβ) linked to aging and disease.

Conclusions:

  • Resveratrol's combined antioxidant and SIRT1-activating properties position it as a promising therapeutic agent for aging prevention.
  • The compound may also be beneficial in treating age-related diseases.
  • Further research into resveratrol's mechanisms could unlock new anti-aging interventions.

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
308
The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
4.1K
Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
945
Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
21.1K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
787
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
19.4K